Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V.
about
The relationship of the factor V Leiden mutation or the deletion-deletion polymorphism of the angiotensin converting enzyme to postoperative thromboembolic events following total joint arthroplastyGuidance for the evaluation and treatment of hereditary and acquired thrombophiliaThe discovery of activated protein C resistanceFactor V Leiden related Budd-Chiari syndromeProthrombotic phenotype of protein Z deficiencyNew aspects in the pathogenesis and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.Factor Va, bound to microparticles released during platelet storage, is resistant to inactivation by activated protein C.APCR, factor V gene known and novel SNPs and adverse pregnancy outcomes in an Irish cohort of pregnant womenPopulation differences in the frequency of the factor V Leiden variant among people with clinically symptomatic protein C deficiency.Increased resistance to activated protein C and factor V Leiden in recurrent abortions. Review of other hypercoagulability factors.Modeling zymogen protein C.Physiological anticoagulation. Resistance to activated protein C and venous thromboembolismOn the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodiesProtein S as an in vivo cofactor to activated protein C in prevention of microarterial thrombosis in rabbits.Newer aspects of micronutrients in chronic disease: copper.The C-terminal region of the factor V B-domain is crucial for the anticoagulant activity of factor V.Evidence-based approach to thrombophilia testing.Acquired activated protein C resistance, thrombophilia and adverse pregnancy outcomes: a study performed in an Irish cohort of pregnant womenIdentification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein CThrombophilia - how far and how much to investigate?Review of thrombophilic States.Genetic variation in F3 (tissue factor) and the risk of incident venous thrombosis: meta-analysis of eight studies.Mutation of the H-helix in antithrombin decreases heparin stimulation of protease inhibition.A gene-centric analysis of activated partial thromboplastin time and activated protein C resistance using the HumanCVD focused genotyping array.The joint association between F5 gene polymorphisms and maternal smoking during pregnancy on preterm delivery.Activated protein C resistance in young adults with central retinal vein occlusionAPC resistance: biological basis and acquired influences.Factor V Leiden and FII 20210 testing in thromboembolic disorders.Inherited and acquired thrombophilias.Role of thrombophilia testing: con.The investigation of a patient with unexpected venous thrombosis.Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S.Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders.Detailed mechanisms of the inactivation of factor VIIIa by activated protein C in the presence of its cofactors, protein S and factor V.Severe digital necrosis in an elderly patient with heterozygous factor V Leiden mutation.Molecular genetics of venous thromboembolism.Protein C pathway, antiphospholipid antibodies and thrombosis.Structural and energetic characteristics of the heparin-binding site in antithrombotic protein C.Genetic Polymorphisms of Hemostatic Factors and Thrombotic Risk in Non BCR-ABL Myeloproliferative Neoplasms: A Pilot Study.Factor V is an anticoagulant cofactor for activated protein C during inactivation of factor Va.
P2860
Q24799211-775E77A0-BAAA-4241-9609-9FAA84F87F0AQ28077943-8E80B74F-4A65-4FA8-9AF5-B068CF0CC4B8Q28188238-FF684393-667F-48F2-8959-BA0CEBCCB3A5Q28345961-E5762DC7-186A-4C21-B4ED-28885B5BF16CQ28509678-6CE68933-61C8-42F4-BA0B-0DAE65FCCF1DQ33339749-1139B548-9109-4C2F-B041-B6A8C3A8535BQ33376731-B8C38CFA-1EB6-4C2C-9EB2-8215721DC9BAQ33538903-CE995A5E-F340-466A-80D9-84656BF3CB54Q33677102-BED230C2-F4D6-4AA9-A5FF-7244A6BD6162Q33780732-C62C24B1-E2E8-4514-88CA-BF68DCF812D3Q34174481-4AFF7F24-E72E-4754-9D63-D3008A8A7CE5Q34181688-E74332B3-3665-4CCB-962E-F3600370283FQ34195707-15823198-0790-4252-A1C9-E192970F572DQ34214354-A4E74EED-B50D-4808-859E-BF3EE939E4C0Q34320567-F4929CF8-F0A5-48B6-AEBB-B2B287DC9753Q34472410-F5D517E9-9842-4941-8134-EC59BB30CA53Q34663749-E51B6694-80DC-4B4C-B96C-C98193D53CC3Q35169691-E4FD2601-556B-41BE-9E5B-45489FFFF0EDQ35824755-FACAB0A5-F54D-482E-B218-07266CF3F603Q35842854-F68EFB9E-B390-4E01-A0F0-ABB7641F8694Q36094372-44D40BDC-7253-4D15-BCF9-D217D68AD32AQ36096028-CB14B75D-D19B-4A86-89DC-028047B588C6Q36408211-67BD2583-9878-4D9A-AC4F-315568DD7380Q36929932-916FF038-F7C4-49CA-A7F1-15D47925DCB9Q37179249-22328B19-5F97-46E2-B82D-C3A30180CDB8Q37318778-4BD9FCD5-448E-4227-9A58-F605407BB9B3Q37651037-C0714B5B-55D6-406E-97F5-79C2AC029D27Q37810984-B6DEFFAC-9EA3-4304-96BD-01D2E069EF60Q38125276-7459EB06-1496-4274-80FE-10210AD3F2A6Q38327537-1278264A-65FA-4BCD-BA3D-00F2FBC04F86Q38641179-41BD2A18-EF76-453F-B8A2-CA9A516AEDB3Q38663583-D905609C-A57A-4746-BD3F-F62313FD41D7Q38830523-6E8BDB95-52F6-4E4C-ADA9-0CBE3220AC1DQ39026107-769D66D7-FAB7-46B0-AB59-05E73C726B8BQ39554656-00965E75-4E6B-4803-996A-D8EE83ADAF60Q40458722-9A74B4BE-3F7C-431E-AAF9-F63DDD182725Q40558476-6467E42A-8EC0-4004-8FC0-9341F08DB545Q40810671-C5D84FED-1871-47F0-9D6D-6B4649E06DE3Q41155968-A4007B28-5F13-484A-A8C4-AE8C9312A086Q41771533-8956B48C-EE31-4F86-929A-B90D6BBC1A42
P2860
Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V.
description
1994 nî lūn-bûn
@nan
1994 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Inherited resistance to activa ...... to be a property of factor V.
@en
type
label
Inherited resistance to activa ...... to be a property of factor V.
@en
prefLabel
Inherited resistance to activa ...... to be a property of factor V.
@en
P2860
P356
P1476
Inherited resistance to activa ...... to be a property of factor V.
@en
P2093
Dahlbäck B
Hildebrand B
P2860
P304
P356
10.1073/PNAS.91.4.1396
P407
P577
1994-02-01T00:00:00Z